Humalog KwikPen

See also: Generic Humalog, Generic Humalog Pen

Humalog KwikPen is a brand name of insulin lispro, approved by the FDA in the following formulation(s):

HUMALOG KWIKPEN (insulin lispro recombinant - injectable; injection)

• 
  Manufacturer: LILLY
  
  Approval date: September 6, 2007
  
  Strength(s): 100 UNITS/ML ^[RLD]

Has a generic version of Humalog KwikPen been approved?

No. There is currently no therapeutically equivalent version of Humalog KwikPen available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Humalog KwikPen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Humalog KwikPen.

See also...

• Humalog KwikPen Consumer Information (Cerner Multum)
• Insulin Lispro Cartridges Consumer Information (Wolters Kluwer)
• Insulin Lispro Vials Consumer Information (Wolters Kluwer)
• Insulin lispro Consumer Information (Cerner Multum)
• Lispro-PFC Advanced Consumer Information (Micromedex)
• Insulin lispro Subcutaneous Advanced Consumer Information (Micromedex)
• Insulin lispro, recombinant Subcutaneous Advanced Consumer Information (Micromedex)
• Insulin Lispro AHFS DI Monographs (ASHP)